Success Story: Supporting Breakthrough Brain Cancer Research Through a National Interest Waiver
Client’s Testimonial:
“I’m very happy with the work of the WeGreened team! They did everything very fast and were willing to help with an additional request of my independent recommender, which was rather hard to fulfill, but they did it excellently!”
On December 4th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Project Scientist in the Field of Brain Cancer (Approval Notice).
General Field: Brain Cancer
Position at the Time of Case Filing: Assistant Project Scientist
Country of Origin: Russia
State of Residence at the Time of Filing: California
Approval Notice Date: December 4th, 2025
Processing Time: 1 year, 10 months, 4 days
Case Summary:
According to one recommender, our client’s findings “may suggest a new standard for GBM treatment that is extremely useful in the fight against cancer.” Starting from this strong support, NAILG prepared a National Interest Waiver petition for a brain cancer researcher whose work helps improve how doctors understand and treat glioblastoma in the United States.
The client’s main goal is clear and practical. He studies how changes in RNA splicing help brain tumors grow, spread, and come back after treatment. Using what he finds, he works on small drug-like molecules that can block these harmful changes so that treatments can work better for people with glioblastoma.
NAILG showed that this work matters for the whole country. Glioblastoma is one of the most aggressive brain cancers, with very poor survival outcomes for many patients. Because of this, research that can lead to new treatment options has strong national importance. Major support from the National Cancer Institute, the National Institute of Neurological Disorders and Stroke, the American Cancer Society, and the National Institutes of Health further proved that trusted U.S. agencies see his work as valuable for public health.
We also highlighted the client’s strong background and record. He holds a Sc.D. in Biological Sciences and has built a career focused on brain cancer research. His portfolio includes 32 peer-reviewed journal articles, 16 abstracts, one co-first-authored preprint, and one co-authored patent, and his work has been cited 1,510 times by other researchers, showing that his results guide ongoing studies worldwide. He has also completed at least 15 reviews for respected journals, which is a clear sign that the field trusts his judgment and expertise.
To show he is well-positioned to keep moving this work forward, NAILG explained how his past projects have already created important tools and ideas. He has helped reveal how RNA splicing shapes brain tumor behavior, helped design new small molecules aimed at hard-to-treat tumor cells, and developed useful methods to study tumor tissue more precisely. These successes, combined with clear plans for future studies, gave USCIS strong reasons to believe that he will continue to make meaningful progress.
Based on this full picture, USCIS agreed that waiving the job offer and labor certification requirements would benefit the United States. The NIW approval allows our client to continue his brain cancer research here, working toward better treatments and better lives for patients and families facing glioblastoma. NAILG is proud to have guided this case and to support his ongoing work for the national interest.